News & Events

OneOme Adds Centra Health as Partner and Provider of RightMed Pharmacogenomic Test

Patients at Centra’s Stroobants Cardiovascular Center will have access to a comprehensive, affordable pharmacogenomic test.

MINNEAPOLIS (Sept. 29, 2016) – Driven to improve patient care and reduce overall healthcare costs, Twin Cities-based pharmacogenomics company OneOme continues to grow its global network and availability of the RightMed test with the announcement of a new partnership with Centra Health. Centra’s...

READ MORE

OneOme announces availability of RightMed pharmacogenomic test

Comprehensive, affordable test can be ordered online by healthcare providers

Minneapolis, Minn., July 19, 2016 – Driven to improve patient care and reduce overall healthcare costs, pharmacogenomics company OneOme announces the global availability of its RightMed test.

The RightMed test is a cost-effective, comprehensive pharmacogenomic analysis of 22 genes provided as a pa...

READ MORE

Pharmacogenomics company OneOme moves steps closer to product launch

Minneapolis company announces new chief executive, headquarters and lab

Minneapolis, Minn., July 12, 2016 – In preparation for its full launch of the RightMed® pharmacogenomic test, OneOme announces Paul Owen as Chief Executive Officer and opens its new headquarters and lab in northeast Minneapolis. By mid-July, OneOme will make the RightMed test commercially availab...

READ MORE

Pharmacogenomics company OneOme achieves more key milestones

Minneapolis company announces new leadership and first exhibition

Minneapolis, Minn., June 20, 2016 – Pharmacogenomics company OneOme is pleased to announce key business milestones in advance of launching its RightMed test.

The RightMed test is a cost-effective, comprehensive, personalized pharmacogenomic analysis of 22 genes provided at the point of care. The t...

READ MORE